Singapore: Global biopharmaceutical firm, Roche, has launched a molecular diagnostic platform, designed for on-demand testing in physician clinics, pharmacies and hospital lab settings, known as cobas Liat System.

Cobas Liat System is a fully automated testing process designed to simplify workflow and enables healthcare professionals to perform molecular testing in a variety of settings with speed, reliability and minimal training. Definitive results are generated in 20 minutes or less to aid a treatment decision.

"The cobas Liat System, enables us to extend the reach of PCR technology," said Mr Paul Brown, head of Roche Molecular Diagnostics. "This system offers significant benefits in testing time and accuracy, over current methods used to diagnose infectious disease within the physician office or urgent care clinic. It eliminates the need for time-consuming confirmatory testing and can provide critical answers to both the healthcare professional and patient during a consultation."